Video Consultation to Reduce Drug Interactions Among Patients Initiating Oral Anti-Cancer Drugs
- Conditions
- Cancer
- Registration Number
- NCT05299671
- Lead Sponsor
- Columbia University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria:<br><br> - Adults age =18 years<br><br> - Patients must have access to a smartphone, tablet, or computer to facilitate a video<br> visit, or be willing to come into the hospital to borrow a tablet for the visit<br><br> - Patients must have received a prescription for a new oral anti-cancer drug within 4<br> weeks of enrollment, not administered as part of a clinical trial<br><br> - Patients must take at least three prescribed, standing oral medications in addition<br> to their newly prescribed anti-cancer drug<br><br>Exclusion Criteria:<br><br> - Patients who do not speak English or Spanish<br><br> - Patients without cognitive capacity to give informed consent for participation<br><br> - Patients uncomfortable with using video-based technology
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of subjects enrolled that complete the 30 minutes consultation and assessments;Rate of absorption interaction;Average of QTc prolongation
- Secondary Outcome Measures
Name Time Method